European pharma stocks fall after Trump slaps 100% tariffs on medicine imports

European pharma stocks fall after Trump slaps 100% tariffs on medicine imports


Stocks listed in Europe were broadly higher on Friday, as investors assessed the latest trade policy announcements out of the White House.

The pan-European Stoxx 600 index was up by 0.2% by around 10:00 a.m. London time (5 a.m. ET), with most sectors in positive territory.

The Stoxx Europe 600 Healthcare index saw rocky trade in the morning, oscillating above and below the flatline. It was last seen trading 0.2% lower.

Overnight, President Donald Trump announced that pharmaceutical imports to the U.S. would be hit with 100% tariffs from Oct. 1. Companies who built manufacturing facilities in America would be exempt, Trump said, but only once they started breaking ground on the construction of U.S. plants.

Previously, Trump had threatened to impose tariffs of up to 200% on pharma imports.

Denmark’s Zealand Pharma was last seen down 2.5%, while Novo Nordisk and Finland’s Orion were also trading more than 2% lower on Friday morning.

However, in a note circulated in the wake of Trump’s announcements, JP Morgan strategists downplayed the impact the new tariffs would have on the pharmaceutical sector.

The “potential 100% tariff should largely be avoidable with us based manufacturing buildout,” they said. “And while there remain a number of unknowns on tonight’s announcement … we continue to see a very manageable overall impact from tariffs to our large cap coverage.”

Trump also announced on his Truth Social platform on Thursday night that heavy trucks would be slapped with 25% tariffs from next month.

The European Union’s own trade policies are also in focus, after German newspaper Handelsblatt reported that the bloc was planning to impose tariffs of up to 50% on Chinese steel in the coming weeks.

On Thursday, European stocks closed lower following the Trump administration’s launch of a national security probe into medical device imports, which could pave the way for further tariffs.

Overnight in Asia, pharma stocks notched losses as investors reacted to the looming U.S. tariffs on the sector.

In terms of economic data, Friday will see the release of Spain’s latest inflation print, U.K. mortgage lending figures, and a report on European economic sentiment.



Source

China’s Xiaomi is planning a next-gen phone chip, but won’t release one yearly like Apple
World

China’s Xiaomi is planning a next-gen phone chip, but won’t release one yearly like Apple

In this photo illustration, the logo of Xiaomi’s XRing O1 chipset is seen on May 19, 2025 in Beijing, China. Xiaomi CEO Lei Jun announced on the evening of May 15 that the company’s self-developed smartphone SoC, XRING 01, will be officially launched in late May. Vcg | Visual China Group | Getty Images Chinese […]

Read More
Fintech Checkout.com’s valuation falls to  billion
World

Fintech Checkout.com’s valuation falls to $12 billion

Guillaume Pousaz, CEO and founder of payment platform Checkout.com, speaking at the annual Web Summit technology conference in Lisbon, Portugal, in 2022. Horacio Villalobos | Getty Images LONDON — Fintech unicorn Checkout.com is giving staff a way of cashing in their shares: buying them out. The London-headquartered payments platform said Friday that it plans to […]

Read More
Barclays CEO double downs on U.K. despite bank tax risk
World

Barclays CEO double downs on U.K. despite bank tax risk

Barclays chief C.S. Venkatakrishnan doubled down on doing business in the United Kingdom even as the British bank faces the growing threat of higher taxes in the country. The executive’s optimism comes as analysts and investors widely expect the U.K. government to target the U.K. banking sector for tax increases in the upcoming Autumn Budget […]

Read More